Deals

Neptune Technologies & Bioressources Raises $2.3M at 9% Premium via Euro Pacific Canada

By |

Neptune Technologies & Bioressources Inc. (NEPT) announced that it has raised $2,267,500 in a Common Stock transaction. The common stock was sold at $2.50 per share, an approximate 9% premium to the market price ($2.29) of NEPT at deal announcement. Euro Pacific Canada, Inc. acted as the exclusive agent on the transaction. The investor was Fiera Capital QSSP II Investment Fund Inc. . via PlacementTracker.

Deals

TG Therapeutics Raises $18M in Underwritten RDO from J.P. Morgan Global Healthcare Fund

By |

TG Therapeutics, Inc. (TGTX) announced that it has raised $18,135,848 in a Registered Direct transaction. The common stock was sold at $6.71 per share. Ladenburg Thalmann & Co., Inc. acted as Underwriter and Roth Capital Partners, LLC and Brean Capital, LLC acted as Financial Advisors on the transaction. The investor was J.P. Morgan Global Healthcare Fund. Note this Placement is subject to customary closing conditions and is expected to close by 03/17/2014.

Deals

Royal Bancshares of Pennsylvania Raises $5.76M at 60% Discount from Emerald Advisers

By |

Royal Bancshares of Pennsylvania, Inc. (RBPAA) announced that it has raised $5,760,000 in a Common Stock transaction. The common stock was sold at $1.20 per share, an approximate 60% discount to the market price ($3.00) of RBPAA at deal announcement. The investors include Emerald Advisers, Inc. . Issuer counsel was Stevens & Lee. The agreement was reached on March 10, 2014.

Deals

Management Network Group Raises $2M at 14% Premium from Strategic Investor

By |

Management Network Group, Inc. (The) (TMNG) announced that it has raised $2,000,000 in a Common Stock transaction. The common stock was sold at $3.28 per share, an approximate 14% premium to the market price ($2.88) of TMNG at deal announcement. A series of 3,400,000 Warrants was issued to the investors in this transaction. The investor was Elutions, Inc.

This Placement is part of a $5.3 million financing. The other $3.3 million was funded in the form of a a non-convertible promissory note sold by the Company's subsidiary Cartesian Limited.